MBX Biosciences announces executive leadership transition to support the company’s next phase of growth Mbx Biosciences - appoints Steve hoe

MBX Biosciences announces executive leadership transition to support the company’s next phase of growth Mbx Biosciences - appoints Steve hoerter as Chairman and CEO - Kent hawryluk steps down as President, CEO and board member - Appoints John smither as Chief Financial Officer - All leadership changes effective immediately